1. Yamamoto, H, Ishimura, M, Ochiai, M, Mitani, K, Hara, T. 2015. BTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector. In Gene therapy, 23, 205-13. doi:10.1038/gt.2015.91. https://pubmed.ncbi.nlm.nih.gov/26280081/
2. Pal Singh, Simar, Dammeijer, Floris, Hendriks, Rudi W. 2018. Role of Bruton's tyrosine kinase in B cells and malignancies. In Molecular cancer, 17, 57. doi:10.1186/s12943-018-0779-z. https://pubmed.ncbi.nlm.nih.gov/29455639/
3. Bi, Ke-Wei, Wei, Xu-Ge, Qin, Xiao-Xue, Li, Bo. 2020. BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining. In Frontiers in oncology, 10, 424. doi:10.3389/fonc.2020.00424. https://pubmed.ncbi.nlm.nih.gov/32351880/
4. Kraft, Monica T, Pyle, Regan, Dong, Xiangyang, Bahna, Sami L, Abraham, Roshini S. 2021. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia. In Clinical immunology (Orlando, Fla.), 229, 108788. doi:10.1016/j.clim.2021.108788. https://pubmed.ncbi.nlm.nih.gov/34182127/
5. Bahal, Sameer, Zinicola, Marta, Moula, Shefta E, Thrasher, Adrian J, Santilli, Giorgia. 2024. Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia. In The Journal of allergy and clinical immunology, 154, 195-208.e8. doi:10.1016/j.jaci.2024.03.003. https://pubmed.ncbi.nlm.nih.gov/38479630/
6. Jain, Preetesh, Wang, Michael. 2019. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. In American journal of hematology, 94, 710-725. doi:10.1002/ajh.25487. https://pubmed.ncbi.nlm.nih.gov/30963600/
7. Brown, Jennifer, Mashima, Kiyomi, Fernandes, Stacey, Fardoun, Rayan, Davids, Matthew. 2024. Mutations Detected in Real World Clinical Sequencing during BTK Inhibitor Treatment in CLL. In Research square, , . doi:10.21203/rs.3.rs-3837426/v1. https://pubmed.ncbi.nlm.nih.gov/38313250/
智鼠故事 
